Spirendolol

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Citation bot (talk | contribs) at 01:08, 5 January 2014 ([458]Add: year, last1, first1, last2, first2, last3, first3, title, volume, issue, pages, journal. Formatted dashes. | Edgar181). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Spirendolol
Names
IUPAC name
4-[3-(tert-Butylamino)-2-hydroxypropoxy]spiro[3H-indene-2,1'-cyclohexane]-1-one
Identifiers
3D model (JSmol)
  • InChI=1S/C21H31NO3/c1-20(2,3)22-13-15(23)14-25-18-9-7-8-16-17(18)12-21(19(16)24)10-5-4-6-11-21/h7-9,15,22-23H,4-6,10-14H2,1-3H3
    Key: YLBMSIZZTJEEIO-UHFFFAOYSA-N
  • CC(C)(C)NCC(COC1=CC=CC2=C1CC3(C2=O)CCCCC3)O
Properties
C21H31NO3
Molar mass 345.483 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

Spirendolol is a beta adrenergic receptor antagonist.[1]

Referencess

  1. ^ Mostaghim, R; Maddox, YT; Ramwell, PW (1986). "Endothelial potentiation of relaxation response to beta adrenoceptor blocking agents". The Journal of pharmacology and experimental therapeutics. 239 (3): 797–801. PMID 2879033.